A detailed history of Seaview Investment Managers LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Seaview Investment Managers LLC holds 81,373 shares of ABT stock, worth $10.9 Million. This represents 2.45% of its overall portfolio holdings.

Number of Shares
81,373
Previous 78,316 3.9%
Holding current value
$10.9 Million
Previous $10.7 Million 3.91%
% of portfolio
2.45%
Previous 3.11%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

BUY
$123.95 - $138.08 $378,915 - $422,110
3,057 Added 3.9%
81,373 $11.1 Million
Q2 2025

Aug 12, 2025

BUY
$123.95 - $138.08 $9.71 Million - $10.8 Million
78,316 New
78,316 $10.7 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $234B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Seaview Investment Managers LLC Portfolio

Follow Seaview Investment Managers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seaview Investment Managers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seaview Investment Managers LLC with notifications on news.